Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Lobe Sciences Ltd., based in Vancouver, announced it has settled a CAD$11,596.22 debt with Gibbsons P.C. The debt arose from legal services previously provided to the company. To satisfy this obligation, Lobe Sciences issued 546,206 common shares to Gibbsons Law P.C. The shares were valued at CAD$0.02123 each and were issued on May 13, 2025. They are subject to regulatory hold periods under Canadian securities laws.

Lobe Sciences, a biopharmaceutical firm, is dedicated to developing therapies for rare and underserved conditions. Through subsidiaries, it is advancing treatments for Sickle Cell Disease and Chronic Cluster Headache, targeting unmet medical needs.